Vascular Neurology, Department of Neurology (Y.X., X.-Q.Z., X.Y., C.W., Y.-L.W., Z.L., Y.W.), Beijing Tiantan Hospital, Capital Medical University, China.
China National Clinical Research Center for Neurological Diseases, Beijing (Y.X., H.G., X.-Q.Z., Y.-L.W., L.-P.L., Q.Z., Z.L., Y.W.).
Stroke. 2021 Apr;52(4):1253-1258. doi: 10.1161/STROKEAHA.120.031329. Epub 2021 Feb 16.
A variety of definitions for minor stroke have been proposed. We aimed to compare the clinical characteristics and outcomes of minor stroke defined as the National Institutes of Health Stroke Scale (NIHSS) score ≤5 versus ≤3.
We retrieved acute ischemic stroke patients with NIHSS score ≤5 in the CSCA study (China Stroke Center Alliance) between August 2015 and 2019. In-hospital clinical outcomes including all-cause mortality, stroke, and myocardial infarction were compared between the NIHSS score ≤5 and NIHSS score ≤3 groups using absolute standardized differences (ASD).
A total of 1 006 798 patients were registered in the CSCA program from 1476 hospitals, 472 352 patients had NIHSS score ≤5, of whom 356 314 patients had NIHSS score ≤3. The in-hospital composite events of death, myocardial infarction, or recurrent stroke were not significantly different between the NIHSS score ≤5 and NIHSS score ≤3 groups (5.6% [26 346/472 352] versus 5.2% [18 682/356 314]; ASD, 1.8). The in-hospital all-cause mortality (0.1% [443/472 352] versus 0.1% [255/356 314]; ASD, <0.01), recurrent ischemic stroke (5.3% [25 026/472 352] versus 5.0% [17 777/356 314]; ASD, 1.4), and hemorrhagic stroke (0.5% [2151/472 352] versus 0.4% [1475/356 314]; ASD, 1.5) were not significantly different between both the NIHSS score ≤5 and NIHSS score ≤3 groups.
Our large-scale study identified that minor stroke using NIHSS scores ≤5 and ≤3 as the definition was comparable with each other regarding in-hospital all-cause mortality, recurrent stroke, and hemorrhagic stroke. This observation may be useful for future comparison studies and clinical trial design.
已经提出了多种关于小卒中的定义。我们旨在比较美国国立卫生研究院卒中量表(NIHSS)评分≤5 与≤3 的小卒中的临床特征和结局。
我们检索了 2015 年 8 月至 2019 年期间 CSCA 研究(中国卒中中心联盟)中 NIHSS 评分≤5 的急性缺血性卒中患者。使用绝对标准化差异(ASD)比较 NIHSS 评分≤5 与 NIHSS 评分≤3 组之间的住院期间临床结局,包括全因死亡率、卒中再发和心肌梗死。
从 1476 家医院的 CSCA 项目中登记了 1006798 例患者,其中 472352 例患者 NIHSS 评分≤5,其中 356314 例患者 NIHSS 评分≤3。NIHSS 评分≤5 与 NIHSS 评分≤3 组之间院内复合事件(死亡、心肌梗死或卒中再发)无显著差异(5.6%[26346/472352] vs 5.2%[18682/356314];ASD,1.8)。院内全因死亡率(0.1%[443/472352] vs 0.1%[255/356314];ASD,<0.01)、缺血性卒中再发(5.3%[25026/472352] vs 5.0%[17777/356314];ASD,1.4)和出血性卒中(0.5%[2151/472352] vs 0.4%[1475/356314];ASD,1.5)在 NIHSS 评分≤5 和 NIHSS 评分≤3 两组之间无显著差异。
我们的大规模研究发现,使用 NIHSS 评分≤5 和≤3 作为定义的小卒中在院内全因死亡率、卒中再发和出血性卒中方面具有可比性。这一观察结果可能对未来的比较研究和临床试验设计有用。